Trial Details
Not recruitingBasic Information
| Clinical ID | c3073 |
|---|---|
| Identifier | NCT02156557 |
| Trial Title | Phase 1B Study of KCC Peptide Application in the Colon |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Colon Polyps;Colorectal Cancer;Inflammatory Bowel Disease (IBD);Colon Polyps;Colorectal Cancer;Inflammatory Bowel Disease (IBD);Colon Polyps;Colorectal Cancer;Inflammatory Bowel Disease (IBD);Colon Polyps;Colorectal Cancer;Inflammatory Bowel Disease (IBD) |
| Interventions | Biological: Colon KCC Heptapeptide;Biological: Colon KCC Heptapeptide;Biological: Colon KCC Heptapeptide;Biological: Colon KCC Heptapeptide |
Participant Information
| Sponsor | Danielle Kim Turgeon |
|---|---|
| City | - |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, ELDER, OLDER_ADULT |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |